Clinical Pharmacokinetics of Drugs in Patients with Heart Failure

Heart Disease and Stroke Statistics—2012 Update

(2011) et al.   CIRCULATION

Pharmacokinetics of the Soluble Guanylate Cyclase Activator Cinaciguat in Individuals With Hepatic Impairment

(2011) Reiner Frey et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Population Pharmacokinetics and Pharmacodynamics of Cinaciguat, a Soluble Guanylate Cyclase Activator, in Patients with Acute Decompensated Heart Failure

(2010) Wolfgang Mueck et al.   CLINICAL PHARMACOKINETICS

A Comprehensive Review of the Loop Diuretics: Should Furosemide Be First Line?

(2009) Kurt A Wargo et al.   ANNALS OF PHARMACOTHERAPY

2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults

(2009) et al.   CIRCULATION

Pharmacokinetics of conivaptan hydrochloride, a vasopressin V1A/V2-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study

(2009) Zhongping Lily Mao et al.   CLINICAL THERAPEUTICS

Population pharmacokinetic and pharmacodynamic modelling of the effects of nicorandil in the treatment of acute heart failure

(2008) Satofumi Iida et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Pharmacokinetics of Intravenous Levosimendan and Its Metabolites in Subjects With Hepatic Impairment

(2008) Jaakko Puttonen et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of the Soluble Guanylate Cyclase Activator Cinaciguat (BAY 58-2667) in Healthy Male Volunteers

(2008) Reiner Frey et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Pharmacokinetics of Ibutilide in Patients with Heart Failure Due to Left Ventricular Systolic Dysfunction

(2008) James E Tisdale et al.   PHARMACOTHERAPY